| |
December 29, 2009
Elekta wins World Class Manufacturing Award
|
Elekta, the world-leading manufacturer of treatment solutions for cancer and brain disorders, has been awarded the prestigious World Class Manufacturing award by The Manufacturer magazine. The World Class Manufacturing award was given in recognition of the quality work produced each year by Elekta manufacturing staff.
Read more... |
|
| |
November 24, 2009
Elekta Compact brings Radiation Therapy to patients in India
|
The Indo-American Cancer Institute and Research Center is the first in India to treat cancer patients with Elekta Compact™, Elekta’s robust, cost-effective linear accelerator for radiation therapy that addresses the cancer care needs of a wider population. The first patient treated on the system was a 52-year-old woman with breast cancer.
Read more... |
|
| |
November 2, 2009
Elekta presents new Image-Guidance Solutions at Capital Markets Day in Chicago, USA
|
At Elekta’s Capital Markets Day held in connection to the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO), in Chicago, USA, Elekta presented new tools for improved clinical precision, workflow efficiency and patient comfort. Highlights included Intuity™*and Symmetry™* advanced image-guidance solutions that build upon the company’s existing expertise.
Read more... |
|
| |
September 9, 2009
Hitachi selects software solutions from Elekta for Proton Therapy Center in Japan
|
Hitachi has selected Elekta to provide workflow enhancing software for its PROBEAT® proton therapy facility at West Medical Center in Nagoya, Japan. Enabling the facility to manage patient data in a chartless, paperless environment, the facility is the second Hitachi-equipped center to implement MOSAIQ®, Elekta’s oncology information system (OIS) for cancer care.
Read more... |
|
| |
September 3, 2009
Elekta Technology At Work In 94 Percent Of America's Top Cancer Hospitals
|
U.S. News & World Report recently issued its annual list of America’s best hospitals and 94 percent of the top cancer hospitals in the country are users of Elekta solutions. For patients throughout the U.S., this means the vast majority of the best cancer treatment facilities also have the best information management, treatment planning and delivery systems available.
Read more... |
|
| |
July 14, 2009
Juntendo University begins VMAT treatments for Prostate Cancer
|
On April 13, Juntendo University (Tokyo, Japan) became the third facility in Japan to begin using Elekta Synergy® to treat prostate patients with Volumetric Modulated Arc Therapy (VMAT). Using VMAT, treatment times can be dramatically shorter and treatment margins are much more conformal than with conventional IMRT. And VMAT requires significantly fewer MUs than conventional IMRT, reducing total MU delivery by up to 50 percent.
Read more... |
|
| |
June 26, 2009
First Elekta VMAT Facility in Japan Approaches One-Year Milestone
|
University of Tokyo Hospital has been treating patients for nearly one year with Elekta Volumetric Modulated Arc Therapy (VMAT). The hospital was the first facility in Japan to use this revolutionary cancer-fighting tool, which can shorten radiation treatment times and provide state-of-the-art precision in dose control to give cancer patients the best possible outcomes.
Read more... |
|
| |
June 18, 2009
Elekta Provides VMAT and Radiosurgery Solutions for New Jersey Health System
|
CentraState Medical Center (Freehold, New Jersey) has purchased two new state-of-the-art Elekta radiation therapy treatment systems, both with Volumetric Modulated Arc Therapy (VMAT). The first site in the world to have both Elekta Axesse and Elekta Infinity, CentraState will offer the most advanced cancer care available to its patients.
Read more... |
|
| |
May 28, 2009
Elekta delivers 3D Brain Mapping Technology to leading German brain research center
|
The University Hospital at Heinrich-Heine-University (HHU, Düsseldorf, Germany) has installed Elekta Neuromag®, a device for non-invasive measurement of brain activity using Magnetoencephalography (MEG) technology. Completely non-invasive and painless, MEG is a powerful tool used for studying normal brain function, as well as brain disorders, such as epilepsy and autism.
Read more... |
|
| |
May 27, 2009
Elekta and The Ottawa Hospital forge long-term strategic partnership agreement
|
Elekta and The Ottawa Hospital (Ottawa, Ontario) have embarked on a decade-long mutual support project that will create an advanced cancer treatment centre. Part of The Ottawa Hospital, The Ottawa Hospital Cancer Centre (TOHCC), will be equipped with radiation therapy systems, as well as workflow enhancing software and treatment planning systems, enabling TOHCC to provide sophisticated therapeutic services in a chartless, paperless clinical environment.
Read more... |
|
| |
May 18, 2009
Elekta and Nucletron combine forces to market leading software
|
Elekta and Nucletron have reached an agreement to market and license Elekta’s software system MOSAIQ®. Nucletron’s existing Oncentra® Visir and Oncentra® Information Management customers will be offered a high-quality solution with excellent future prospects of continued innovation from the world’s largest supplier of oncology software.
Read more... |
|
| |
May 11, 2009
U.K. Cancer Centre Begins Innovative Radiotherapy Treatment With Four Elekta Systems
|
Velindre Cancer Centre (Cardiff, Wales, U.K.) has awarded Elekta with a multiple Elekta Synergy® order, bringing the department’s installation to four. All four systems will be used to facilitate Volumetric Modulated Arc Therapy (VMAT), a treatment technique that offers shorter treatment times while providing more precise control of the radiation dose to maximize safety to nearby normal tissues. This latest order will see the replacement of existing third party vendor equipment together with implementing MOSAIQ® as the sole patient information system.
Read more... |
|
| |
October 20, 2008
Elekta Neuromag® users publish groundbreaking advances in Magnetoencephalography
|
Magnetoencephalography (MEG) is a powerful tool for studying normal brain function and brain disorders and Elekta Neuromag® is the world’s most advanced and most used MEG system, providing real-time mapping of brain activity by non-invasively measuring in both spatial and high temporal (millisecond) resolutions the magnetic fields produced by the brain. Regarded as the most efficient method for tracking brain activity, MEG technology enables neurosurgeons, neurologists and those in related fields to non-invasively record human brain activity in real time, better and more accurately than before.
Read more... |
|
| |
September 30, 2008
Elekta commits to Supporting the Further Development of Advanced Health Care in Ukraine - ...
|
Elekta, a global leader in advanced technology for treating cancer and brain disorders, today announced a donation of Leksell Stereotactic System® for minimally invasive brain surgery to the International Charitable Foundation "Ukraine 3000" for which Mrs. Kateryna Yuschenko, wife of the President of Ukraine is the prime guardian. This donation was presented in the presence of Her Majesty Queen Silvia of Sweden, founder of the World Childhood Foundation. The system will be used for treating a wide range of brain disorders at one of the leading neurosurgery hospitals in Ukraine.
Read more... |
|
| |
September 22, 2008
Clinicians in Odense, Denmark, first in Scandinavia to offer new Innovative Technology from ...
|
Odense University Hospital in Denmark has become the first Scandinavian cancer centre to choose Elekta VMAT (Volumetric intensity Modulated Arc Therapy) to expand the capabilities of the hospital’s radiation oncology department. The addition of this solution to the range of treatment techniques will provide physicians with the ability to treat cancer tumors with improved precision and accuracy, while at the same time significantly reduce treatment times.
Read more... |
|
| |
September 16, 2008
Elekta Announces Availability of Elekta Infinity with VMAT Technology for Fast, More Precise ...
|
ASTRO Booth #601 -- Elekta, pioneering significant innovations and clinical solutions for cancer and neurological conditions, today announced new product offerings from the Elekta Group. Topping the list of innovations is Elekta Infinity; the company’s most advanced digital linear accelerator, now available to customers in the United States. Elekta Infinity increases speed and precision in delivering Volumetric Modulated Arc Therapy (VMAT), offering patients shortened treatment times with the highest degree of precision.
Read more... |
|
| |
September 16, 2008
Elekta Announces Availability of Elekta Infinity with VMAT Technology for Fast, More Precise ...
|
ASTRO Booth #601 -- Elekta, pioneering significant innovations and clinical solutions for cancer and neurological conditions, today announced new product offerings from the Elekta Group. Topping the list of innovations is Elekta Infinity; the company’s most advanced digital linear accelerator, now available to customers in the United States. Elekta Infinity increases speed and precision in delivering Volumetric Modulated Arc Therapy (VMAT), offering patients shortened treatment times with the highest degree of precision.
Read more... |
|
| |
September 15, 2008
Presbyterian Cancer Center to offer cancer patients high-end VMAT treatments with the ...
|
Presbyterian Cancer Center – Dallas, a joint venture between Presbyterian Hospital of Dallas and Texas Oncology, PA, recently installed an Elekta Infinity system, enabling the facility to begin treating patients with Volumetric Modulated Arc Therapy (VMAT). Elekta Infinity is the facility’s first image guided linear accelerator, and will allow the Center to offer patients shortened treatment times with the highest degree of precision.
Read more... |
|
| |
September 15, 2008
PRESBYTERIAN CANCER CENTER TO OFFER CANCER PATIENTS HIGH-END VMAT TREATMENTS WITH THE ...
|
Presbyterian Cancer Center – Dallas, a joint venture between Presbyterian Hospital of Dallas and Texas Oncology, PA, recently installed an Elekta Infinity system, enabling the facility to begin treating patients with Volumetric Modulated Arc Therapy (VMAT). Elekta Infinity is the facility’s first image guided linear accelerator, and will allow the Center to offer patients shortened treatment times with the highest degree of precision.
Read more... |
|
| |
September 12, 2008
Elekta Announces Availability of ERGO++ For VMAT Treatment Planning
|
Elekta, a human care company pioneering significant innovations and clinical solutions for treating cancer and neurological conditions, today announced, the clinical release of ERGO++ 1.7.1. for Volumetric Modulated Arc Therapy (VMAT), a new treatment technique offering shorter treatment times with the highest degree of precision. Building upon the experience of Arc Modulation, ERGO++ for VMAT can be used with a wide range of equipment, including mini and micro MLCs in addition to the Elekta MLCi (10mm) and Beam Modulator (4mm, full interdigitation).
Read more... |
|
| |
September 9, 2008
The Canadian Association of Radiation Oncology and Elekta Award Research Fellowship
|
Radiation oncology and medical technology groups award the second annual
CARO-Elekta Research Fellowship to Dr. Scott Carlyle Morgan
Vancouver, BC – The Canadian Association of Radiation Oncology (CARO), along with international medical-technology group Elekta, are pleased to award the 2008 CARO-Elekta Research Fellowship to Radiation Oncologist, Dr. Scott Carlyle Morgan. The $75,000 fellowship, provided by Elekta, will enable Dr. Morgan to conduct research with the Uro-Oncology Unit at the Royal Marsden Hospital in London, England with Professor David Dearnaley. His research will revolve around a newly emerging approach to treating prostate cancer that involves the delivery of very precise radiation treatment only to regions of the prostate gland that harbour cancer. He is scheduled to begin his research in November 2008.
Read more... |
|
| |
August 29, 2008
CMS, Inc., An Elekta Company, Announces First Cancer Patients Treated with Monaco™ ...
|
CMS, Inc., an Elekta Company and worldwide leader in radiation treatment planning and workflow management solutions, today announced that three sites have delivered clinical treatments utilizing Monaco™, its next-generation Intensity Modulated Radiotherapy (IMRT) treatment planning system. Allegheny General Hospital in Pittsburgh, Pennsylvania, Erasmus Medical Center in Rotterdam, Netherlands, and Froedtert Memorial Lutheran Hospital in Milwaukee, Wisconsin, have all begun producing treatment plans with the application.
Read more... |
|
| |
August 29, 2008
CMS, Inc., an Elekta Company, announces first cancer patients treated with Monaco™ ...
|
CMS, Inc., an Elekta Company and worldwide leader in radiation treatment planning and workflow management solutions, announced that three sites have delivered clinical treatments utilizing Monaco™, its next-generation Intensity Modulated Radiotherapy (IMRT) treatment planning system. Allegheny General Hospital in Pittsburgh, Pennsylvania, Erasmus Medical Center in Rotterdam, Netherlands, and Froedtert Memorial Lutheran Hospital in Milwaukee, Wisconsin, have all begun producing treatment plans with the application.
Read more... |
|
| |
August 26, 2008
Elekta receives CE mark clearance for ‘Everyday Radiation Therapy’ ...
|
Elekta recently announced that it has received CE mark clearance to distribute Elekta Compact™, the latest addition to its line of treatment systems, offering clinicians an easy to implement, more affordable solution for radiation therapy. CE Mark clearance from the European Union certifies Elekta Compact has met health, safety and environmental requirements for consumer safety.
Read more... |
|
| |
July 25, 2008
Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting
|
The Elekta Family of Companies will showcase their unique line of cancer treatment solutions at the 2008 American Association of Physicists in Medicine (AAPM) annual meeting, demonstrating how the joint forces of Elekta, IMPAC and CMS are delivering cutting-edge radiation therapy planning and delivery solutions that streamline the treatment process to create a better experience for patients, as well as enhance clinician efficiency.
Read more... |
|
| |
July 25, 2008
Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting
|
The Elekta Family of Companies will showcase their unique line of cancer treatment solutions at the 2008 American Association of Physicists in Medicine (AAPM) annual meeting, demonstrating how the joint forces of Elekta, IMPAC and CMS are delivering cutting-edge radiation therapy planning and delivery solutions that streamline the treatment process to create a better experience for patients, as well as enhance clinician efficiency.
Read more... |
|
| |
June 16, 2008
Elekta VMAT 510(k) Clearance Welcomed by US Radiation Oncologists
|
Elekta has received FDA 510(k) clearances for its groundbreaking Elekta VMAT solution, allowing US cancer specialists to both plan and deliver radiation using a technique which has the potential to revolutionize the practice of radiation oncology. This news has been eagerly anticipated by US cancer clinics as it offers both significant benefits to their patients and the opportunity to increase patient volumes.
Read more... |
|
| |
June 16, 2008
Elekta VMAT 510(k) Clearance Welcomed by US Radiation Oncologists
|
Elekta has received FDA 510(k) clearances for its groundbreaking Elekta VMAT solution, allowing US cancer specialists to both plan and deliver radiation using a technique which has the potential to revolutionize the practice of radiation oncology. This news has been eagerly anticipated by US cancer clinics as it offers both significant benefits to their patients and the opportunity to increase patient volumes.
Read more... |
|
| |
June 3, 2008
San Antonio Community Hospital Commissions Leksell Gamma Knife® Perfexion™ To Serve ...
|
Physicians at California’s San Antonio Community Hospital in Upland, will soon treat patients using the new Leksell® Gamma Knife Perfexion™. A revolutionary alternative to traditional open-brain surgery and daily radiation treatments, Leksell Gamma Knife Perfexion, developed by the international medical technology group Elekta, delivers focused doses of radiation without making an incision to treat brain tumors and other brain disorders.
Read more... |
|
| |
June 3, 2008
San Antonio Community Hospital Commissions Leksell Gamma Knife® Perfexion™ to serve ...
|
Physicians at California’s San Antonio Community Hospital in Upland, will soon treat patients using the new Leksell® Gamma Knife Perfexion™. A revolutionary alternative to traditional open-brain surgery and daily radiation treatments, Leksell Gamma Knife Perfexion, developed by the international medical technology group Elekta, delivers focused doses of radiation without making an incision to treat brain tumors and other brain disorders.
Read more... |
|
| |
May 26, 2008
Leksell Gamma Knife® Perfexion™ receives regulatory approval in Japan
|
The Japanese Ministry for Health, Labor and Welfare, MHLW, has given approval for Leksell Gamma Knife® Perfexion™, the world-leading clinical solution for non-invasive radiosurgical treatments of tumors, vascular malformations and other brain disorders. Elekta, the international medical technology group and developer of Gamma Knife® surgery, will now be able to deliver and install this advanced technology at new and existing customer sites in Japan.
Read more... |
|
| |
May 21, 2008
Elekta Sees Record Attendance and Record Number of Submitted Abstracts at International Leksell ...
|
Leksell Gamma Knife, Society Meeting, LGK, Neurosurgeons, Radiosurgery Award, Flickinger, Rasmussen, Marsland, Butler Hospital, Lindquist, Cromwell Hospital, Obsessive Compulsive Disorder, Regis, Perfexion
Read more... |
|
| |
May 21, 2008
Elekta sees record attendance and record number of submitted abstracts at International Leksell ...
|
At the 14th International Leksell Gamma Knife® Society Meeting on May 18-22, over 500 participants including neurosurgeons, radiation oncologists and other medical specialists using Leksell Gamma Knife for treatment of tumors and other brain disorders convened at the historic Château Frontenac Hotel in Quebec, Canada. During the meeting, 260 oral and poster presentations covered treatment of malignant and benign brain tumors, functional neurosurgery, imaging & biology as well as physics & technology. On Wednesday, May 21, the prestigious Pioneers in Radiosurgery Award was presented to John Flickinger, M.D., Professor of Radiation Oncology and Neurological Surgery at the University of Pittsburgh for his early pioneering work on prediction of complications following Gamma Knife® surgery.
Read more... |
|
| |
May 19, 2008
Australian Safety Agency orders Elekta Synergy® as gold standard for Calibration and Dosimetry
|
Elekta, world-leading provider of radiation therapy and radiosurgery solutions, is pleased to announce that the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) has joined other world-class physics standards centers with its order of an Elekta linear accelerator. ARPANSA will accept delivery of an Elekta Synergy® system this summer, and will utilize the Elekta system’s high level of stability for its national physics measurements.
Read more... |
|
| |
May 2, 2008
Elekta receives an order to deliver comprehensive suit of advanced cancer treatment ...
|
In a collaborative effort, Macquarie University, incorporating The Australian School of Advanced Medicine, together with Dalcross Private Hospital has launched an ambitious project to improve access to advanced radiosurgery and radiation therapy for patients in Sydney and across Australia’s New South Wales region. The medical technology group Elekta, based in Stockholm, Sweden, has been selected as the main provider of a comprehensive suit of cancer and neurosurgical treatment solutions and supporting IT systems to the new Macquarie University Private Hospital, currently under construction.
Read more... |
|
| |
April 25, 2008
Elekta announces first Linear Accelerator order in New Zealand
|
Elekta, a world leader in clinical solutions for radiosurgery and radiation therapy, has finalized its first-ever New Zealand order. Auckland Radiation Oncology Limited (ARO) have decided to invest in a new Elekta Synergy® system with MOSAIQ™ EMR and Elekta VMAT, for delivery in April.
Read more... |
|
| |
April 24, 2008
Elekta’s New Line of Stereotactic Treatment Solutions is Redefining Excellence in ...
|
Elekta, a global leader in minimally invasive neurosurgery will feature its latest line of stereotactic solutions at the 76th Annual Meeting of the American Association of Neurological Surgeons’ (AANS), April 26 - May 1 in Chicago, Illinois. Highlights include Leksell Gamma Knife® Perfexion™ and Elekta Axesse™, two stereotactic treatment solutions that are creating new possibilities for the most challenging cases.
Read more... |
|
| |
March 4, 2008
Elekta completes the acquisition of CMS
|
The international medical technology group Elekta AB (publ) (STO: EKTAb) today announced the completion of its announced acquisition of CMS, Inc. for total cash consideration representing an enterprise value of USD 75 M.
Read more... |
|
| |
February 18, 2008
Elekta signs agreement to acquire CMS
|
Elekta AB (publ) (STO:EKTAb) a world leader in clinical solutions for radiation therapy and radiosurgery, today announced that it has signed a purchase agreement to acquire CMS Inc. for a total cash consideration representing an enterprise value of USD 75 M. Closing of the transaction is expected in March.
Read more... |
|
| |
January 21, 2008
Elekta to supply CHU de Poitiers Hospital Center in France with Advanced Technology for Image ...
|
CHU (University Hospital Center) de Poitiers has selected Elekta as the main partner in an ambitious program to improve radiation therapy treatment capacity in the Poitou-Charente region. Replacing equipment from a different vendor, the hospital recently assigned Elekta to deliver three Elekta Synergy® digital linear accelerator systems for intensity modulated and image guided radiation therapy. The order is valued at close to EUR 5 M.
Read more... |
|
| |
January 10, 2008
Elekta displays innovative cancer treatment solutions at JASTRO 2007
|
Elekta, a global leader in radiation oncology and non-invasive neurosurgery solutions, demonstrated a very strong presence at the 20th annual meeting of the Japanese Society for Therapeutic Radiology and Oncology (JASTRO). With over 1,800 radiation oncologists and radiation therapists in attendance, JASTRO was held December 13-15, 2007 at the Fukuoka Convention Center.
Read more... |
|
| |
January 10, 2008
Elekta displays innovative cancer treatment solutions at JASTRO 2007
|
Elekta, a global leader in radiation oncology and non-invasive neurosurgery solutions, demonstrated a very strong presence at the 20th annual meeting of the Japanese Society for Therapeutic Radiology and Oncology (JASTRO). With over 1,800 radiation oncologists and radiation therapists in attendance, JASTRO was held December 13-15, 2007 at the Fukuoka Convention Center.
Read more... |
|
| |
January 8, 2008
Elekta negotiates to acquire CMS
|
Acquisition of leading treatment planning software developer would strengthen Elekta’s offering and accelerate the company’s expansion into high growth oncology informatics
Read more... |
|
| |
January 8, 2008
Elekta negotiates to acquire CMS
|
Acquisition of leading treatment planning software developer would strengthen Elekta’s offering and accelerate the company’s expansion into high growth oncology informatics
Read more... |
|
| |
October 30, 2007
Beaumont Hospital, Royal Oak treats its first patients with Elekta Axesse™
|
Beaumont Hospital, Royal Oak (Royal Oak, Michigan, USA) has performed its first treatments using the new Elekta Axesse™, the ultimate whole-body cancer treatment system. Elekta Axesse sets new standards for precision and therapeutic efficacy in stereotactic radiation therapy, which involves three-dimensional CT imaging for tumor targeting accuracy. The new robotic, image-guided stereotactic radiation system treats cancer patients quickly and effectively with highly accurate tumor targeting.
Read more... |
|
| |
October 30, 2007
Beaumont Hospital, Royal Oak treats its first patients with Elekta Axesse™
|
Beaumont Hospital, Royal Oak (Royal Oak, Michigan, USA) has performed its first treatments using the new Elekta Axesse™, the ultimate whole-body cancer treatment system. Elekta Axesse sets new standards for precision and therapeutic efficacy in stereotactic radiation therapy, which involves three-dimensional CT imaging for tumor targeting accuracy. The new robotic, image-guided stereotactic radiation system treats cancer patients quickly and effectively with highly accurate tumor targeting.
Read more... |
|
| |
October 29, 2007
Elekta announces Elekta Infinity – a new System for Faster, more precise Treatment of ...
|
Elekta, a global leader in radiation oncology and non-invasive neurosurgery solutions, announced Elekta Infinity*, the definitive new digital linear accelerator optimized for delivering Volumetric Intensity Modulated Arc Therapy* (VMAT), a very fast Intensity Modulated Radiation Therapy (IMRT) treatment delivered in single or multiple arcs, at the 49th Annual Meeting of The American Society for Therapeutic Radiology and Oncology (ASTRO). The meeting is being held October 28-November 1, at the Los Angeles Convention Center.
Read more... |
|
| |
October 29, 2007
Elekta announces Elekta Infinity – a new System for Faster, more precise Treatment of ...
|
Elekta, a global leader in radiation oncology and non-invasive neurosurgery solutions, announced Elekta Infinity*, the definitive new digital linear accelerator optimized for delivering Volumetric Intensity Modulated Arc Therapy* (VMAT), a very fast Intensity Modulated Radiation Therapy (IMRT) treatment delivered in single or multiple arcs, at the 49th Annual Meeting of The American Society for Therapeutic Radiology and Oncology (ASTRO). The meeting is being held October 28-November 1, at the Los Angeles Convention Center.
Read more... |
|
| |
October 27, 2007
IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
|
IBA (Ion Beam Applications S.A.: Reuters IBAB.BR and Bloomberg IBAB.BB) and Elekta AB (publ) (Stockholm, Sweden: EKTA.ST), edtoday announced a global particle therapy collaboration program to optimize the seamless integration of proton therapy delivery and information management systems within the radiation oncology environment. Both companies currently showcase their products at the 49th Annual Meeting of ASTRO (American Society for Therapeutic Radiology and Oncology) held in Los Angeles, CA, USA, from October 28 to November 1, 2007.
Read more... |
|
| |
October 27, 2007
IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
|
IBA (Ion Beam Applications S.A.: Reuters IBAB.BR and Bloomberg IBAB.BB) and Elekta AB (publ) (Stockholm, Sweden: EKTA.ST), edtoday announced a global particle therapy collaboration program to optimize the seamless integration of proton therapy delivery and information management systems within the radiation oncology environment. Both companies currently showcase their products at the 49th Annual Meeting of ASTRO (American Society for Therapeutic Radiology and Oncology) held in Los Angeles, CA, USA, from October 28 to November 1, 2007.
Read more... |
|
| |
October 18, 2007
Elekta announces new Cancer Care Solutions and Highlights Personalized Efficiency at ASTRO 2007
|
Elekta, a global leader in radiation oncology and non-invasive neurosurgery solutions, will feature advances in cancer care at the 49th Annual Meeting of The American Society for Therapeutic Radiology and Oncology (ASTRO) that dramatically reduce treatment times and increase efficiency. The meeting will be held October 28 - November 1 at the Los Angeles Convention Center (Los Angeles, California, USA). Elekta will showcase innovative offerings that optimize productivity and workflow, empowering health care professionals to spend more time on patient care. One important highlight will be the announcement of a new Elekta solution for clinical Volumetric Intensity Modulated Arc Therapy* (VMAT) that more precisely targets tumors and protects surrounding healthy tissue, while drastically reducing radiation therapy treatment times.
Read more... |
|
| |
September 26, 2007
Elekta selected to supply Advanced Radiation Therapy Capability to Greece’s largest ...
|
Elekta, a world leader in advanced radiation therapy and radiosurgery has been awarded a Contract by the Diagnostic and Therapeutic Center of Athens – HYGEIA S.A. – to supply and install three linear accelerator systems, including one Elekta Axesse™ stereotactic image guided treatment system, a comprehensive network and information management system and a long-term service contract. The Contract is valued at over EUR 8 M.
Read more... |
|
| |
September 25, 2007
Two new Italian Cancer Centers select Advanced Radiation Treatment Technology from Elekta
|
Elekta has been selected by two progressive Italian hospitals opening up new radiation therapy clinics, to supply advanced and clinically proven cancer treatment systems for intensity modulated and image guided radiation therapy (IMRT & IGRT). The two clinics will play an important role in their respective region to provide first class radiation therapy and to increase cancer treatment
capacity.
Read more... |
|
| |
September 12, 2007
Elekta Displays Complete Volumetric Intensity Modulated Arc Therapy Solutions at ESTRO
|
Elekta is pleased to announce the development of a comprehensive solution for planning and performing Volumetric Intensity Modulated Arc Therapy (VMAT)*. The complete offering of Elekta VMAT solutions are being featured in the Elekta booth at this year’s European Society of Therapeutic Radiation Oncologists (ESTRO) meeting in Barcelona, September 8-13, 2007. Performing VMAT with Elekta enables helical-like conformality and can help reduce total treatment time even with daily use of Elekta’s proven X-ray Volume Imaging system.
Read more... |
|
| |
September 12, 2007
Elekta Displays Complete Volumetric Intensity Modulated Arc Therapy Solutions at ESTRO
|
Elekta is pleased to announce the development of a comprehensive solution for planning and performing Volumetric Intensity Modulated Arc Therapy (VMAT)*. The complete offering of Elekta VMAT solutions are being featured in the Elekta booth at this year’s European Society of Therapeutic Radiation Oncologists (ESTRO) meeting in Barcelona, September 8-13, 2007. Performing VMAT with Elekta enables helical-like conformality and can help reduce total treatment time even with daily use of Elekta’s proven X-ray Volume Imaging system.
Read more... |
|
| |
September 10, 2007
Elekta Launches new Linear Accelerator at 2007 ESTRO to expand Cancer Treatment Availability
|
Elekta today unveiled a new member of the Elekta family of linear accelerators at the European Society for Therapeutic Radiology and Oncology (ESTRO) 2007 meeting. At an unveiling ceremony in the Elekta booth, Elekta President & CEO Tomas Puusepp announced the launch of Elekta Compact™, a new addition to Elekta's product line of linear accelerators that offers an easy to implement, more affordable solution for radiation therapy.
Read more... |
|
| |
September 10, 2007
Elekta Launches new Linear Accelerator at 2007 ESTRO to expand Cancer Treatment Availability
|
Elekta today unveiled a new member of the Elekta family of linear accelerators at the European Society for Therapeutic Radiology and Oncology (ESTRO) 2007 meeting. At an unveiling ceremony in the Elekta booth, Elekta President & CEO Tomas Puusepp announced the launch of Elekta Compact™, a new addition to Elekta's product line of linear accelerators that offers an easy to implement, more affordable solution for radiation therapy.
Read more... |
|
|
